972 Platinum-based chemotherapy reverses human MDSC phenotype and suppressive activity on CD8+ T cells

• Yueyun Ding,
• Tyler Simpson,
• Rupal Bhatt,
• Ana Lako,
• Christine Tauras,
• Zoe Bleicher,
• Timothy Consedine,
• Benjamin Chen,
• Sangeeth George,
• David Balli,
• Sharmila Chamling Rai,
• Ailem Schrand,
• Joe DeBettencourt,
• William J Geese,
• Noe Ramirez-Alejo

Affiliations

Yueyun Ding

1Bristol Myers Squibb, Cambridge, MA, USA

Tyler Simpson

Aff1 Jounce Therapeutics Cambridge MA USA

Rupal Bhatt

Aff70 grid.239395.70000000090118547Beth Israel Deaconess Medical Center Boston MA USA

Ana Lako

13 Dana-Farber/Brigham and Women`s Cancer Center, Boston, Massachusetts, USA

Christine Tauras

1Bristol Myers Squibb, Cambridge, MA, USA

Zoe Bleicher

Bristol-Myers Squibb, Cambridge, MA, USA

Timothy Consedine

Bristol-Myers Squibb, Cambridge, MA, USA

Benjamin Chen

2Bristol Myers Squibb, Lawrenceville, NJ, USA

Sangeeth George

4Bristol Myers Squibb Co Cambridge, Cambridge, MA, USA

David Balli

6Bristol Myers Squibb, Princeton, NJ, USA

Sharmila Chamling Rai

2Bristol Myers Squibb, Cambridge, MA, USA

Ailem Schrand

1Bristol Myers Squibb, Cambridge, MA, USA

Joe DeBettencourt

1Bristol Myers Squibb, Cambridge, MA, USA

William J Geese

3Bristol Myers Squibb, Princeton Pike, NJ, USA

Noe Ramirez-Alejo

1Bristol Myers Squibb, Cambridge, MA, USA